ADMA BIOLOGICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ADMA BIOLOGICS, INC. (ADMA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.19 million shares for the 12-month period ending 2022-12-31, per its 10-K filed 2024-02-28.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2024-02-28
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2021-03-31 was 1.44M shares, a 24.35% increase year-over-year.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-12-31 was 70.00K shares, a 369.80% increase year-over-year.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-09-30 was 165.91K shares, a 159.24% increase year-over-year.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-06-30 was 73.60K shares, a 21.07% decline year-over-year.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.19M shares, a 37.01% decline from fiscal 2021.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 1.90M shares, a 29.09% increase from fiscal 2020.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 1.47M shares, a 2.63% decline from fiscal 2019.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 1.51M shares, a 29.22% increase from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | 1.19M shares 10-K · filed 2024-02-28 | ||||
| 2021-12-31 | 1.90M shares 10-K · filed 2024-02-28 | ||||
| 2021-03-31 | 1.44M shares 10-Q · filed 2021-05-12 | 1.51M shares derived: sum of 2 quarters · filed 2022-03-24 | 1.68M shares derived: sum of 3 quarters · filed 2022-03-24 | 1.75M shares derived: sum of 4 quarters · filed 2022-03-24 | |
| 2020-12-31 | 70.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | 235.91K shares derived: sum of 2 quarters · filed 2022-03-24 | 309.51K shares derived: sum of 3 quarters · filed 2022-03-24 | 1.47M shares 10-K · filed 2022-03-24 | |
| 2020-09-30 | 165.91K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 239.51K shares derived: sum of 2 quarters · filed 2020-11-05 | 1.40M shares 10-Q · filed 2020-11-05 | 1.41M shares derived: sum of 4 quarters · filed 2021-05-12 | |
| 2020-06-30 | 73.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | 1.23M shares 10-Q · filed 2020-08-05 | 1.25M shares derived: sum of 3 quarters · filed 2021-05-12 | 1.31M shares derived: sum of 4 quarters · filed 2021-05-12 | |
| 2020-03-31 | 1.16M shares 10-Q · filed 2021-05-12 | 1.17M shares derived: sum of 2 quarters · filed 2021-05-12 | 1.24M shares derived: sum of 3 quarters · filed 2021-05-12 | 1.33M shares derived: sum of 4 quarters · filed 2021-05-12 | |
| 2019-12-31 | 14.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | 78.90K shares derived: sum of 2 quarters · filed 2020-03-13 | 172.15K shares derived: sum of 3 quarters · filed 2020-03-13 | 1.51M shares 10-K · filed 2020-03-13 | |
| 2019-09-30 | 64.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | 157.25K shares derived: sum of 2 quarters · filed 2019-11-06 | 1.49M shares 10-Q · filed 2019-11-06 | 1.60M shares derived: sum of 4 quarters · filed 2020-03-13 | |
| 2019-06-30 | 93.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 1.43M shares 10-Q · filed 2019-08-08 | 1.53M shares derived: sum of 3 quarters · filed 2020-03-13 | 1.59M shares derived: sum of 4 quarters · filed 2020-03-13 | |
| 2019-03-31 | 1.34M shares 10-Q · filed 2019-05-08 | 1.44M shares derived: sum of 2 quarters · filed 2020-03-13 | 1.50M shares derived: sum of 3 quarters · filed 2020-03-13 | 1.63M shares derived: sum of 4 quarters · filed 2020-03-13 | |
| 2018-12-31 | 102.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | 164.14K shares derived: sum of 2 quarters · filed 2020-03-13 | 298.34K shares derived: sum of 3 quarters · filed 2020-03-13 | 1.17M shares 10-K · filed 2020-03-13 | |
| 2018-09-30 | 61.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | 196.00K shares derived: sum of 2 quarters · filed 2018-11-09 | 1.06M shares 10-Q · filed 2018-11-09 | 1.10M shares derived: sum of 4 quarters · filed 2019-03-13 | |
| 2018-06-30 | 134.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | 1.00M shares 10-Q · filed 2018-08-10 | 1.04M shares derived: sum of 3 quarters · filed 2019-03-13 | 1.12M shares derived: sum of 4 quarters · filed 2019-03-13 | |
| 2018-03-31 | 868.70K shares 10-Q · filed 2018-05-14 | 902.40K shares derived: sum of 2 quarters · filed 2019-03-13 | 988.40K shares derived: sum of 3 quarters · filed 2019-03-13 | 2.66M shares derived: sum of 4 quarters · filed 2019-03-13 | |
| 2017-12-31 | 33.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | 119.70K shares derived: sum of 2 quarters · filed 2019-03-13 | 1.79M shares derived: sum of 3 quarters · filed 2019-03-13 | 1.98M shares 10-K · filed 2019-03-13 | |
| 2017-09-30 | 86.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | 1.76M shares derived: sum of 2 quarters · filed 2017-11-03 | 1.94M shares 10-Q · filed 2017-11-03 | 1.94M shares derived: sum of 4 quarters · filed 2018-03-29 | |
| 2017-06-30 | 1.67M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | 1.86M shares 10-Q · filed 2017-08-11 | 1.86M shares derived: sum of 3 quarters · filed 2018-03-29 | 1.86M shares derived: sum of 4 quarters · filed 2018-03-29 | |
| 2017-03-31 | 182.00K shares 10-Q · filed 2017-05-12 | 182.00K shares derived: sum of 2 quarters · filed 2018-03-29 | 182.00K shares derived: sum of 3 quarters · filed 2018-03-29 | 197.00K shares derived: sum of 4 quarters · filed 2018-03-29 | |
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | 0.00 shares derived: sum of 2 quarters · filed 2018-03-29 | 15.00K shares derived: sum of 3 quarters · filed 2018-03-29 | 100.98K shares 10-K · filed 2018-03-29 | |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 15.00K shares derived: sum of 2 quarters · filed 2016-11-10 | 100.98K shares 10-Q · filed 2016-11-10 | 220.98K shares derived: sum of 4 quarters · filed 2017-02-24 | |
| 2016-06-30 | 15.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | 100.98K shares 10-Q · filed 2016-08-12 | 220.98K shares derived: sum of 3 quarters · filed 2017-02-24 | 302.48K shares derived: sum of 4 quarters · filed 2017-02-24 | |
| 2016-03-31 | 85.98K shares 10-Q · filed 2016-05-13 | 205.98K shares derived: sum of 2 quarters · filed 2017-02-24 | 287.48K shares derived: sum of 3 quarters · filed 2017-02-24 | 288.48K shares derived: sum of 4 quarters · filed 2017-02-24 | |
| 2015-12-31 | 120.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | 201.50K shares derived: sum of 2 quarters · filed 2017-02-24 | 202.50K shares derived: sum of 3 quarters · filed 2017-02-24 | 432.50K shares 10-K · filed 2017-02-24 | |
| 2015-09-30 | 81.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | 82.50K shares derived: sum of 2 quarters · filed 2015-11-10 | 312.50K shares 10-Q · filed 2015-11-10 | 312.50K shares derived: sum of 4 quarters · filed 2016-03-23 | |
| 2015-06-30 | 1.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | 231.00K shares 10-Q · filed 2015-08-11 | 231.00K shares derived: sum of 3 quarters · filed 2016-03-23 | 231.00K shares derived: sum of 4 quarters · filed 2016-03-23 | |
| 2015-03-31 | 230.00K shares 10-Q · filed 2015-05-12 | 230.00K shares derived: sum of 2 quarters · filed 2016-03-23 | 230.00K shares derived: sum of 3 quarters · filed 2016-03-23 | ||
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | 0.00 shares derived: sum of 2 quarters · filed 2016-03-23 | 221.93K shares 10-K · filed 2016-03-23 | ||
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | 221.93K shares 10-Q · filed 2014-11-10 | |||
| 2014-06-30 | 221.93K shares 10-Q · filed 2014-08-11 | ||||
| 2013-12-31 | 58.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | 58.55K shares derived: sum of 2 quarters · filed 2015-03-09 | 58.55K shares derived: sum of 3 quarters · filed 2015-03-09 | 84.13K shares 10-K · filed 2015-03-09 | |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2013-11-12 | 25.59K shares 10-Q · filed 2013-11-12 | ||
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | 25.59K shares 10-Q · filed 2013-08-12 | |||
| 2013-03-31 | 25.59K shares 10-Q · filed 2013-05-14 | ||||
| 2012-12-31 | 643.32K shares 10-K · filed 2014-03-28 | 506.56K shares 10-K · filed 2013-03-06 | |||
| 2012-06-30 | 13.26K shares 10-Q · filed 2012-08-14 | 106.07K shares 10-Q · filed 2012-08-14 | |||
| 2011-12-31 | 0.00 shares 10-K · filed 2013-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |